An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

Part of paid clinical trials in Morgantown, West Virginia.

Sponsor
Novo Nordisk A/S
Study ID
NCT01511393
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No treatment given — OTHER
    None. Non-interventional study.

Study Details

This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.

Key Dates

Start date
Jan 31, 2012
Status verified
Jun 2023
Primary completion
Dec 31, 2039
Completion
Dec 31, 2039

Study Design

Enrollment
6,750 participants (estimated)

Arms

  • Arm: Questionnaire
    None. Non-interventional study.

Primary Outcome Measure

Annual incidence of MTC in the US to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market. [ Time Frame: Up to 15 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
United BioSource, LLCMorgantownWest Virginia26505-8065-

Find similar trials in Morgantown, WV

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
United BioSource, LLC· Morgantown, WV

Related Studies